Get started
Author

Callum T. Kaye

Observed names: C Kaye, C. Kaye, C.T. Kaye, Callum Kaye, Callum T Kaye, Kaye, Callum
Observed institutions: University of Siena, National Health Service, Alberta Health Services, St. Michael's Hospital, St Thomas' Hospital, University of Alberta, Queen Mary University of London, University of Aberdeen, Aberdeen Royal Infirmary, Ghent University Hospital, Royal Devon and Exeter Hospital, North Manchester General Hospital, Derriford Hospital, Centre Hospitalier Universitaire de Nantes, NHS Grampian, Hospital Clínico Universitario de Valencia, Renewable Energy Alaska Project, Cancer Research UK Clinical Trials Unit, Blizard Institute, Canadian Critical Care Trials Group, University of Birmingham, University of Genoa, Nantes Université
ORCID: 0000-0002-6904-7048
Observed ORCID: 0000-0002-6904-7048
OpenAlex ID: A5070925997
Mapping the human genetic architecture of COVID-19
2021 · COVID-19 Host Genetics Initiative, COVID-19 Host Genetics InitiativeLeadership, et al. · Nature · 983
Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries
2021 · Vincenzo Russotto, Sheila Nainan Myatra, et al. · JAMA · 638
PDF
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 493
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369
Whole-genome sequencing reveals host factors underlying critical COVID-19
2022 · Athanasios Kousathanas, Erola Pairo-Castineira, et al. · Nature · 326
PDF
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 290
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
2023 · Erola Pairo-Castineira, Konrad Rawlik, et al. · Nature · 224
PDF
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
2021 · Hesham Abdelhady, Marwa Abdelrazik, et al. · JAMA · 210
PDF
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
2022 · Simin  Florescu, Delia Stanciu, et al. · JAMA · 146
PDF
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2022 · Simin  Florescu, Delia Stanciu, et al. · JAMA · 136
PDF
Multiple organ dysfunction after trauma
2019 · E Cole, S Gillespie, et al. · British journal of surgery · 135
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129
A second update on mapping the human genetic architecture of COVID-19
2023 · The COVID-19 Host Genetics Initiative, Leadership, et al. · Nature · 118
PDF
Extubation in neurocritical care patients: the ENIO international prospective study
2022 · Raphaël Cinotti, Julio Cesar Mijangos, et al. · Intensive Care Medicine · 111
PDF
Landiolol and Organ Failure in Patients With Septic Shock
2023 · Tony Whitehouse, Anower Hossain, et al. · JAMA · 107
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
2021 · Yaseen M. Arabi, Anthony C. Gordon, et al. · Intensive Care Medicine · 99
PDF
Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study
2021 · Nazir Lone, Joanne McPeake, et al. · The Lancet Regional Health - Europe · 93
PDF
Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial
2023 · Ron Wald, Stephane Gaudry, et al. · Intensive Care Medicine · 71
PDF
Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis
2022 · Gennaro De Pascale, Massimo Antonelli, et al. · Intensive Care Medicine · 68
PDF
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
2023 · Simin  Florescu, Delia Stanciu, et al. · JAMA · 63
PDF
Intravenous Vitamin C for Patients Hospitalized With COVID-19
2023 · The LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators, Simin  Florescu, et al. · JAMA · 53
PDF
Efficacy and adverse events profile of videolaryngoscopy in critically ill patients: subanalysis of the INTUBE study
2023 · Vincenzo Russotto, Jean Baptiste Lascarrou, et al. · British Journal of Anaesthesia · 50
PDF
Clinical practice and effect of carbon dioxide on outcomes in mechanically ventilated acute brain-injured patients: a secondary analysis of the ENIO study
2024 · Chiara Robba, Denise Battaglini, et al. · Intensive Care Medicine · 44
PDF
Works count: 68
Citation count: 6,129
H-index: 28
I10-index: 38
Year
Topic
Type